Theme Immune Checkpoint Inhibitors

General

The objective of this webinar series is to create a platform for international stakeholders to discuss critical topics and challenges they face when treating patients with immunotherapy, with a key goal of providing education and bringing awareness to the barriers currently impeding equitable access to IO around the globe. 

Moderator: Ahmad A. Tarhini MD. PhD - H. Lee Moffitt Cancer Center & Research Institute

Faculty:

  • Frederico Perego Costa, MD - Autem Therapeutics, Centro de Oncologia of Hospital Siro Libanês
  • Precious Takondwa Makondi, MBBS, PhD - Kamuzu Central Hospital, National Cancer Center
  • Ali Shamseddine, MD - American University of Beirut Medical Center

Webinar 3/6 content:

This webinar will examine how immune checkpoint inhibitors are being utilized around the globe and in resource limited settings. It will provide a forum for physicians from Brazil, Lebanon, and Malawi to discuss their experience in evaluating checkpoint inhibitors as a treatment option as well as how they overcame challenges related to manufacturing, access, regulation, and toxicity management.

Date and Location

Time From 5.00 pm to 6.30 pm
Duration 1.5 hours
Start date Thursday, August 15, 2024
Location Online

Costs and registration

Register here for this free webinar series.